Analysen zu Novo Nordisk
| 17.10.25 | Novo Nordisk Outperform | Bernstein Research | |
| 13.10.25 | Novo Nordisk Neutral | UBS AG | |
| 10.10.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.10.25 | Novo Nordisk Neutral | UBS AG | |
| 06.10.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.10.25 | Novo Nordisk Neutral | UBS AG | |
| 01.10.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 30.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.09.25 | Novo Nordisk Neutral | UBS AG | |
| 19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.25 | Novo Nordisk Neutral | UBS AG | |
| 15.09.25 | Novo Nordisk Neutral | UBS AG | |
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |
| 29.08.25 | Novo Nordisk Neutral | UBS AG | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Novo Nordisk Neutral | UBS AG | |
| 12.08.25 | Novo Nordisk Neutral | UBS AG | |
| 11.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 08.08.25 | Novo Nordisk Neutral | UBS AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Novo Nordisk Halten | DZ BANK | |
| 07.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Novo Nordisk Neutral | UBS AG | |
| 05.08.25 | Novo Nordisk Neutral | UBS AG | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 30.07.25 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 29.07.25 | Novo Nordisk Halten | DZ BANK | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 09.01.26 | Glencore Outperform | RBC Capital Markets | |
| 09.01.26 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 09.01.26 | Renault Hold | Jefferies & Company Inc. | |
| 09.01.26 | Porsche vz. Hold | Jefferies & Company Inc. | |
| 09.01.26 | Stellantis Buy | Jefferies & Company Inc. | |
| 09.01.26 | Volkswagen Buy | Jefferies & Company Inc. | |
| 09.01.26 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 09.01.26 | BMW Hold | Jefferies & Company Inc. | |
| 09.01.26 | Renault Overweight | Barclays Capital | |
| 09.01.26 | Stellantis Equal Weight | Barclays Capital | |
| 09.01.26 | Porsche Automobil Underweight | Barclays Capital | |
| 09.01.26 | Volkswagen Overweight | Barclays Capital | |
| 09.01.26 | Mercedes-Benz Group Equal Weight | Barclays Capital | |
| 09.01.26 | Porsche vz. Underweight | Barclays Capital | |
| 09.01.26 | BMW Underweight | Barclays Capital | |
| 09.01.26 | TeamViewer Outperform | RBC Capital Markets | |
| 09.01.26 | BNP Paribas Overweight | JP Morgan Chase & Co. | |
| 09.01.26 | Sartorius Stedim Biotech Sector Perform | RBC Capital Markets | |
| 09.01.26 | Sartorius vz. Sector Perform | RBC Capital Markets | |
| 08.01.26 | ING Group Sector Perform | RBC Capital Markets | |
| 08.01.26 | TRATON Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 08.01.26 | Ferrari Hold | Jefferies & Company Inc. | |
| 08.01.26 | PUMA Sector Perform | RBC Capital Markets | |
| 08.01.26 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 08.01.26 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 08.01.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Nestlé Equal Weight | Barclays Capital | |
| 08.01.26 | AIR France-KLM Equal Weight | Barclays Capital | |
| 08.01.26 | Redcare Pharmacy Buy | Deutsche Bank AG | |
| 08.01.26 | LEG Immobilien Buy | Deutsche Bank AG | |
| 08.01.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | GSK Hold | Deutsche Bank AG | |
| 08.01.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Pfizer Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | grenke Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.26 | Saint-Gobain Buy | Jefferies & Company Inc. | |
| 08.01.26 | Zalando Buy | Jefferies & Company Inc. | |
| 08.01.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | Roche Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | VINCI Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | Ahold Delhaize Underweight | JP Morgan Chase & Co. | |
| 08.01.26 | Wienerberger Sell | UBS AG | |
| 08.01.26 | Knorr-Bremse Neutral | JP Morgan Chase & Co. | |
| 08.01.26 | Henkel vz. Market-Perform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.